a.amankwah

TL2 · Tampere

Contributes reviews on supplier material. Based in Tampere.

Joined 19 October 2024 · last posted 3d

77 posts, newest first. Showing up to 150.

CJC-1295 with and without DAC: what the modification does Replied, post #122 · Compounds › Secretagogues & GH axis · 25 Jul 2026 · 0 likes A mass result for a short peptide is more discriminating than for a long one, because a single residue difference is a larger proportion of the total. That makes…
Which categories are strict and which are relaxed, honestly Replied, post #38 · Start Here › Welcome · 22 Jul 2026 · 28 likes If you want a fast orientation, read three solved topics in the subcategory you care about. Solved means somebody said the answer worked, which is more signal than…
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #119 · Outcomes › Body composition · 21 Jul 2026 · 21 likes Picking up post #118: that is the part I would want checked first. Lean mass preservation is a question about a distribution, not about a value, and treating it as a…
MS/MS sequence confirmation: what it costs and when it is worth it Replied, post #6 · Analytics › Mass spectrometry · 18 Jul 2026 · 2 likes Taking post #3 at face value and following it one step further. Tandem mass spectrometry with fragmentation gives sequence information that intact mass cannot. It is…
Seven-day rolling means and why weekly readings mislead Replied, post #45 · Outcomes › Progress reports · 17 Jul 2026 · 1 like Seven-day rolling was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #30 · Analytics › HPLC & UHPLC · 12 Jul 2026 · 9 likes Taking post #27 at face value and following it one step further. Mobile-phase preparation is a genuine source of between-laboratory variation. Acid concentration and…
Documenting a supplier's response to a discrepancy Replied, post #29 · Sourcing › Vendor reports · 3 Jul 2026 · 7 likes This follows post #28 rather than contradicting it. Do not adjust a reported figure. Post what the laboratory said and put your interpretation in a separate sentence.
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #34 · Compounds › Secretagogues & GH axis · 30 Jun 2026 · 11 likes Research-use-only secretagogues are not approved for human use. That statement is doing real work in this subcategory, where the published evidence base is thinner than…
Primary endpoint hierarchies and why order matters — one year on Replied, post #28 · Evidence › Trials · 28 Jun 2026 · 2 likes Dropout is information: high dropout rates can indicate tolerability problems or lower efficacy than the summary suggests. Where the analysis handled dropouts matters.…
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #48 · Compounds › Secretagogues & GH axis · 24 Jun 2026 · 31 likes Secretagogues and glucose tolerance is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #13 · Analytics › Impurities & related substances · 20 Jun 2026 · 29 likes Incomplete deprotection leaves a protecting group attached, raising the mass substantially and usually pushing retention much later. A late-eluting peak on a peptide…
Trust level 3 requirements: a clarification — does this still hold? Replied, post #67 · Meta › Announcements · 19 Jun 2026 · 13 likes Adding a note of thanks rather than an opinion. I did not know most of that.
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #116 · Practice › Reconstitution · 18 Jun 2026 · 0 likes The lyophilised cake should be inspected before anything is added. A shrunken, collapsed or discoloured cake is information, and it is information you lose the moment…
What to include when your question involves a chromatogram — one year on Replied, post #33 · Start Here › How to Ask · 11 Jun 2026 · 0 likes Avoid "any advice?" at the end. It is so generic that people do not know which part of the post it refers to. Pick the specific part and ask that specific question…
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #77 · Data & Tools › Datasets · 8 Jun 2026 · 0 likes Where I part company with post #75, and it is a narrow parting. Self-reported, unblinded, self-selected data has known biases and is still worth collecting, provided…
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #87 · Outcomes › Body composition · 1 Jun 2026 · 1 like Narrowing post #86, because the general version has more than one answer. On Lean mass preservation: the maintained page in the documentation commons covers the general…
Packaging that arrived damaged: documenting it properly Replied, post #11 · Sourcing › Logistics · 17 May 2026 · 0 likes Post #9 is the version of this I will quote in future. One addition. Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #13 · Compounds › Tirzepatide · 1 May 2026 · 20 likes Tirzepatide and nausea came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
Transporting a vial for a weekend away — a second dataset Replied, post #32 · Practice › Storage & stability · 19 Apr 2026 · 17 likes Coming back to post #31, because the follow-up matters more than the original answer. Visible particulate is a strong signal in the other direction: it is a reason to…
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #13 · Compounds › Repair & healing peptides · 18 Apr 2026 · 16 likes Answering the question post #9 raises rather than the one it answers. Anecdote is the whole of the human evidence base here, and this community's convention is to say…
Vomiting: when it is expected and when it is a reason to stop — one year on Started this topic · Practice › Side effects · 23 Mar 2026 · 55 likes Vomiting: when it is expected and when it is a reason to stop — one year on Writing it up because I had to work it out twice and would rather nobody else did. Reporting…
Which fields on a certificate actually matter, ranked Replied, post #15 · Analytics › COA interpretation · 15 Mar 2026 · 0 likes The fields that make one usable: lot identifier matching the container, test date, method identification specific enough to reproduce, the result as a number, and the…
Research-use-only status: what it means legally and practically Replied, post #12 · Compounds › Other compounds · 9 Mar 2026 · 11 likes Posting my research-use-only status numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a…
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #17 · Lounge › Introductions · 8 Mar 2026 · 1 like What to include: your name or handle, how you found the community, what brings you here, maybe something about yourself that seems relevant (clinician, researcher,…
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #5 · Compounds › Repair & healing peptides · 7 Mar 2026 · 20 likes Adding a reference point for Reading a preclinical wound-healing model. Mine is a single case, collected without controls, and I am posting the method alongside it so…
Waist circumference technique and its repeatability Replied, post #58 · Outcomes › Progress reports · 2 Mar 2026 · 25 likes Practical experience of waist circumference technique, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what…
The most useful thing you learned here that was not the answer you came for Replied, post #24 · Lounge › Off topic · 2 Mar 2026 · 5 likes Digression worth the space: the archive is starting to be genuinely long. There are questions here whose good answer is four years old and still correct, and that only…
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #130 · Practice › Dosing & titration · 21 Feb 2026 · 0 likes I had written a reply contradicting post #128 and deleted it. Here is what survived. Going back down a step is not a failure and the trials allowed it. Several…
Guidelines revision: what changed and why — one year on Replied, post #73 · Meta › Announcements · 20 Feb 2026 · 22 likes If you are new and reading this thread for the answer to Guidelines revision: the answer is conditional, the conditions are in the third reply, and the rest of the…
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #24 · Practice › Administration · 9 Feb 2026 · 31 likes A new needle for each injection is not fussiness. A needle blunts on first use and a blunted needle is the reason the second injection hurts more than the first. Anyone…
Non-inferiority margins: how they are chosen and how they are abused — a second dataset Replied, post #10 · Evidence › Trials · 18 Jan 2026 · 16 likes Narrowing post #7, because the general version has more than one answer. What would change my mind on Non-inferiority margins is a second dataset collected by someone…
Reused chromatograms across lots: how to spot it — what changed since Replied, post #11 · Analytics › COA interpretation · 14 Jan 2026 · 32 likes Building on post #9 rather than restating it. Reused chromatograms across lots has been discussed here with more heat than it deserves, mostly because two definitions…
Amylin receptor signalling and satiety — what changed since Replied, post #15 · Pharmacology › Receptor biology · 12 Jan 2026 · 8 likes This is the answer, and the reason it is the answer is the more useful part.
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #52 · Access › Pricing · 3 Jan 2026 · 0 likes Price changes is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
Selection into a registry and what it does to the estimate Replied, post #3 · Evidence › Study critique · 1 Jan 2026 · 7 likes On the opening post — agreed on the reasoning, with one qualification. Sample size calculated on an optimistic effect estimate produces a trial that is underpowered for…
How to ask about something you suspect is a bad idea Replied, post #38 · Start Here › How to Ask · 27 Dec 2025 · 15 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either. The general case is well covered; this…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #77 · Compounds › Semaglutide · 25 Dec 2025 · 25 likes Semaglutide half-life is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #3 · Evidence › Journal club · 16 Dec 2025 · 0 likes Confirming post #2 from a second method, which matters more than confirming it from a second person. An hour is enough for one paper read properly and not enough for…
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #18 · Research Methods › N-of-1 designs · 10 Nov 2025 · 32 likes Record everything that changed, not just the intervention. Personal experiments are confounded by life, and the confounders are only recoverable if they were written…
What pooling buys you and what it destroys Replied, post #51 · Evidence › Meta-analyses · 26 Oct 2025 · 0 likes One more thing on pooling buys that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the apparent…
NHS criteria and how they are applied in practice — the long version Replied, post #10 · Regional › UK & Ireland · 11 Oct 2025 · 0 likes Worth separating two things that post #6 runs together. Regional variation in NHS: access varies dramatically by region depending on local commissioning decisions and…
Insurance and replacement policies, compared — the long version Replied, post #18 · Sourcing › Logistics · 22 Sep 2025 · 0 likes Good question, well framed, and I would like to see it answered properly.
Second pass at: A history of disordered eating: proceeding carefully Replied, post #130 · Wellbeing › Mental health · 10 Sep 2025 · 14 likes Confirming post #129 from a second method, which matters more than confirming it from a second person. I changed my mind about history of disordered eating after…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #85 · Data & Tools › Datasets · 9 Sep 2025 · 1 like Worth stating the null on Aggregated purity results across four before we explain it: the observation may be nothing. That possibility deserves a sentence and usually…
Why catalogue breadth is not evidence of anything — what changed since Replied, post #24 · Compounds › Other compounds · 21 Aug 2025 · 22 likes This subcategory exists because some people will research compounds outside the main groups discussed here. The standard of evidence and honesty about its limits…
Coming back to: A community side-effect dataset, with its response rate and biases Started this topic · Data & Tools › Datasets · 8 Jul 2025 · 0 likes On the subject in the title: A community side-effect dataset, with its response rate and biases Working notes rather than a conclusion. Reading back through what has…
Follow-up: Documentation that appears only after payment Replied, post #64 · Sourcing › Red flags · 10 May 2025 · 1 like Worth separating two things that post #60 runs together. One more thing on Documentation that took me far too long to see: the two figures people quote are not…
Ipamorelin selectivity claims and where they came from Replied, post #33 · Compounds › Secretagogues & GH axis · 30 Apr 2025 · 17 likes The arithmetic in post #30 is right; the assumption feeding it is the part to check. I would keep ipamorelin selectivity claims and the decision it usually gets used…
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #14 · Evidence › Journal club · 29 Apr 2025 · 17 likes What would change my mind on STEP 4 is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so than…
UK access routes, dated and sourced — a second dataset Replied, post #67 · Regional › UK & Ireland · 22 Apr 2025 · 0 likes Occupational health screening: some UK occupations require medical checks. Disclosure of weight-loss medication might be relevant to employment screening; understand…
Requesting a page: what makes a good request Replied, post #49 · Documentation › Wiki requests · 8 Apr 2025 · 21 likes The strongest case for a new document is a question that recurs and has a good answer buried in a reply. That is the promotion criterion as written. I keep a log of…
Second pass at: Manufacturer assistance programmes and their eligibility rules Replied, post #17 · Access › Pricing · 24 Mar 2025 · 18 likes What would change my mind on Manufacturer assistance programmes is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I…
Research-use-only labelling: what it means and what it does not — the long version Replied, post #108 · Sourcing › Regulatory · 18 Mar 2025 · 29 likes On Research-use-only labelling I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them…
Maintainer handover: how it works Replied, post #30 · Meta › Wiki maintenance · 15 Mar 2025 · 0 likes Reporting rather than recommending, on maintainer handover. What happened is above. Whether it should have is a different question and not one I am qualified to answer.
Reading an MS report that only gives you a single number Replied, post #25 · Analytics › Mass spectrometry · 9 Mar 2025 · 6 likes Confirming post #24 from a second method, which matters more than confirming it from a second person. Quantitation by MS: most quantitation is done by LC-UV detection…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #12 · Sourcing › Regulatory · 27 Feb 2025 · 0 likes Worth separating two things that post #11 runs together. Import restrictions vary by compound and by jurisdiction: what is a controlled substance in one place is legal…
Distinguishing a deletion sequence by mass alone Replied, post #122 · Analytics › Mass spectrometry · 23 Feb 2025 · 0 likes Post #120 put the caveat in the right place and I want to underline it. Mass accuracy is expressed in parts per million. It is the difference between observed and…
Follow-up: What other technical communities get right that we do not Replied, post #22 · Lounge › Off topic · 21 Feb 2025 · 0 likes Personal stories: if you want to talk about what led you to this compound, your journey, or how the change has affected your life, the Lounge is the place for that. I…
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #52 · Pharmacology › Receptor biology · 15 Feb 2025 · 0 likes Bias and desensitisation: receptors can be biased (preferentially activating some downstream pathways over others) and can desensitise over time (responding less to the…
Protein density versus volume when you cannot eat much Replied, post #59 · Nutrition & Training › Protein & intake · 2 Feb 2025 · 10 likes Where I part company with post #55, and it is a narrow parting. Temperature and texture change what is tolerable for a lot of people during the first weeks, and that is…
When to suspect the method rather than the sample Replied, post #73 · Analytics › Method validation · 28 Jan 2025 · 22 likes An independent laboratory's method being different from the supplier's is not a discrepancy. It becomes one only when the results differ by more than both methods'…
SURPASS-2 and the comparator dose question that will not go away Replied, post #108 · Compounds › Tirzepatide · 18 Jan 2025 · 3 likes Everything in post #104 holds. The case it does not cover is the one I have. Where I would push back on the SURPASS-2 consensus is the confidence, not the direction.…
Recovery when intake is low: what to cut first Replied, post #17 · Nutrition & Training › Resistance training · 10 Jan 2025 · 32 likes An update on my earlier recovery post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
A promotion I argued against, and why I lost Replied, post #47 · Documentation › Doc review · 1 Jan 2025 · 9 likes This follows post #44 rather than contradicting it. Reviewing your own nomination is fine and is not sufficient. Somebody else has to read it for the process to mean…
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #42 · Practice › Interactions · 28 Dec 2024 · 10 likes What I would check first on Grapefruit is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.
The topic list is dense — is that deliberate? Replied, post #71 · Meta › Site feedback · 23 Dec 2024 · 0 likes Accessibility: screen readers, keyboard navigation, contrast, font size — if something is not accessible to you, report it. Accessibility matters.
Identical chromatograms across two different lots Replied, post #64 · Sourcing › Red flags · 19 Dec 2024 · 1 like A note on how identical chromatograms gets discussed rather than on identical chromatograms itself: the confident posts get the replies and the careful ones get…
[2026 update] Step therapy requirements and how to satisfy them Replied, post #67 · Access › Insurance & coverage · 13 Dec 2024 · 16 likes Same experience here, different supplier, so it is at least not unique to one of them.
Tirzepatide storage and stability: what is published versus what is assumed — does this… Replied, post #12 · Compounds › Tirzepatide · 3 Dec 2024 · 4 likes Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means steady state is reached slightly faster and the post-dose…
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #8 · Data & Tools › Calculators · 1 Dec 2024 · 14 likes Tools that run entirely in the browser send nothing anywhere, which matters more to some people here than others and is worth stating either way. Someone should write…
Coming back to: When to suspect the method rather than the sample Replied, post #8 · Analytics › Method validation · 29 Nov 2024 · 6 likes Transfer between laboratories: a method can be transferred from one lab to another, but the receiving lab needs to demonstrate that they can achieve the same…
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #37 · Compounds › Semaglutide · 21 Nov 2024 · 26 likes The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…
EMA product information as a primary source — does this still hold? Replied, post #53 · Regional › European Union · 16 Nov 2024 · 20 likes Germany: BfArM implements EU framework. Statutory insurance (the majority) excludes "lifestyle medicines" including weight management. Private prescription is common.…
Promotion criteria, and the one that stops most nominations Replied, post #92 · Documentation › Doc review · 22 Oct 2024 · 6 likes A promotion that is declined should leave the topic linked from wherever the question recurs, so the work is not lost. I would want the raw data before agreeing with my…
Guidelines revision: what changed and why Replied, post #72 · Meta › Announcements · 27 Jul 2024 · 27 likes On post #70 — agreed on the reasoning, with one qualification. The number people quote for guidelines revision is a central estimate presented without its interval, and…
Follow-up: Conditions that change the calculus rather than forbidding it Replied, post #7 · Safety › Contraindications · 15 Jul 2024 · 0 likes Two things can be true about Conditions at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument here is people…
The mass-error checker and its intended scope Replied, post #57 · Data & Tools › Calculators · 17 Jun 2024 · 9 likes Dose equivalence calculator: compounds have different potencies. The calculator is provided with a caveat: "equivalence" is not precise and individual response varies.…